Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
Holding CRVS?
Track your performance easily

Corvus Pharmaceuticals (CRVS) Balance Sheet

534 Followers

Corvus Pharmaceuticals Balance Sheet

Corvus Pharmaceuticals's total assets for Q2 2024 were $64.56M, an increase of 61.06% from the previous quarter. CRVS total liabilities were $6.22M for the fiscal quarter, a -7.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 45.55M$ 68.24M$ 109.45M$ 85.53M$ 83.62M
Total Liabilities
$ 6.87M$ 12.13M$ 12.29M$ 13.38M$ 5.64M
Total Equity Gross Minority
$ 38.70M$ 56.10M$ 97.16M$ 72.15M$ 71.11M
Total Capitalization
$ 38.68M$ 57.49M$ 99.76M$ 73.38M$ 71.11M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Corvus Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis